Article
Assessment of a Polygenic Risk Score in Screening for Prostate Cancer
9 Apr 2025
Abstract excerpt
BACKGROUND: The incidence of prostate cancer is increasing. Screening with an assay of prostate-specific antigen (PSA) has a high rate for false positive results. Genomewide association studies have identified common germline variants in persons with prostate cancer, which can be used to calculate a polygenic risk score associated with risk of prostate cancer. METHODS: We recruited persons 55 to 69 years of age...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
